|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 540.05 INR | -1.57% |
|
-3.16% | -5.45% |
| 09/12 | Creamline Dairy Products Limited Signs Memorandum of Understanding with the Government of Telangana | CI |
| 28/11 | Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.61 | 6.09 | 3.83 | 5.61 | 6.79 | |||||
Return on Total Capital | 8.38 | 8.14 | 5.01 | 7.37 | 9.13 | |||||
Return On Equity % | 14.85 | 16.28 | 10.87 | 12.69 | 14.61 | |||||
Return on Common Equity | 16.13 | 18.64 | 13.11 | 14.82 | 17.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 26.06 | 23.65 | 20.71 | 23.66 | 25.35 | |||||
SG&A Margin | 6.21 | 5.43 | 5.07 | 5.86 | 6.03 | |||||
EBITDA Margin % | 9.03 | 7.99 | 5.43 | 7.25 | 8.63 | |||||
EBITA Margin % | 6.81 | 6.1 | 3.64 | 5.3 | 6.54 | |||||
EBIT Margin % | 6.8 | 6.09 | 3.62 | 5.26 | 6.5 | |||||
Income From Continuing Operations Margin % | 5.55 | 5.05 | 3.15 | 3.77 | 4.3 | |||||
Net Income Margin % | 5.01 | 4.85 | 3.22 | 3.77 | 4.58 | |||||
Net Avail. For Common Margin % | 5.01 | 4.85 | 3.22 | 3.77 | 4.58 | |||||
Normalized Net Income Margin | 3.85 | 3.71 | 2.07 | 3.09 | 3.98 | |||||
Levered Free Cash Flow Margin | -5.94 | -5.99 | 4.84 | 2.02 | 6.04 | |||||
Unlevered Free Cash Flow Margin | -5.49 | -5.53 | 5.49 | 2.72 | 6.92 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.32 | 1.6 | 1.69 | 1.71 | 1.67 | |||||
Fixed Assets Turnover | 3.08 | 3.93 | 4.14 | 3.84 | 3.66 | |||||
Receivables Turnover (Average Receivables) | 7.45 | 9.35 | 12.26 | 17.43 | 17.15 | |||||
Inventory Turnover (Average Inventory) | 4.67 | 4.98 | 5.04 | 5.03 | 5.04 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.08 | 1.06 | 0.97 | 1.04 | 1 | |||||
Quick Ratio | 0.46 | 0.39 | 0.28 | 0.28 | 0.29 | |||||
Operating Cash Flow to Current Liabilities | -0 | -0.05 | 0.37 | 0.31 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 49.01 | 39.04 | 29.76 | 20.99 | 21.28 | |||||
Days Outstanding Inventory (Average Inventory) | 78.24 | 73.36 | 72.47 | 72.77 | 72.47 | |||||
Average Days Payable Outstanding | 77.97 | 39.49 | 34.69 | 33.39 | 40.22 | |||||
Cash Conversion Cycle (Average Days) | 49.28 | 72.9 | 67.54 | 60.38 | 53.54 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 41.58 | 59.46 | 52.23 | 48.47 | 53.64 | |||||
Total Debt / Total Capital | 29.37 | 37.29 | 34.31 | 32.65 | 34.91 | |||||
LT Debt/Equity | 6.81 | 2.51 | 5.34 | 12.88 | 20.82 | |||||
Long-Term Debt / Total Capital | 4.81 | 1.57 | 3.51 | 8.68 | 13.55 | |||||
Total Liabilities / Total Assets | 48.71 | 51.85 | 49.99 | 48.78 | 52.82 | |||||
EBIT / Interest Expense | 9.43 | 8.18 | 3.48 | 4.71 | 4.61 | |||||
EBITDA / Interest Expense | 12.78 | 10.94 | 5.35 | 6.72 | 6.33 | |||||
(EBITDA - Capex) / Interest Expense | 7.12 | 6.56 | 1.67 | 3.11 | 4.62 | |||||
Total Debt / EBITDA | 1.77 | 2.36 | 2.75 | 1.98 | 1.67 | |||||
Net Debt / EBITDA | 1.68 | 2.31 | 2.69 | 1.9 | 1.63 | |||||
Total Debt / (EBITDA - Capex) | 3.18 | 3.94 | 8.82 | 4.27 | 2.29 | |||||
Net Debt / (EBITDA - Capex) | 3.02 | 3.86 | 8.64 | 4.09 | 2.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -8.54 | 32.86 | 12.78 | 1.93 | -1.79 | |||||
Gross Profit, 1 Yr. Growth % | 12.84 | 21.42 | -1.24 | 16.42 | 5.2 | |||||
EBITDA, 1 Yr. Growth % | 51.42 | 20.48 | -23.29 | 36.03 | 17.99 | |||||
EBITA, 1 Yr. Growth % | 78.44 | 23.08 | -32.57 | 48.35 | 22.54 | |||||
EBIT, 1 Yr. Growth % | 78.71 | 23.12 | -32.88 | 48.03 | 22.75 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.63 | 20.59 | -29.53 | 21.7 | 12.22 | |||||
Net Income, 1 Yr. Growth % | 2.47 | 28.32 | -25.01 | 19.13 | 19.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 69.3 | 27.86 | -37.15 | 52.55 | 28.09 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 2.45 | 28.29 | -25.01 | 19.1 | 19.4 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.58 | 15.66 | -39.66 | -9.6 | 10.25 | |||||
Inventory, 1 Yr. Growth % | 10.35 | 44.61 | -4.3 | 0.97 | -9.09 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.69 | 2.37 | 11.58 | 7.95 | -1.49 | |||||
Total Assets, 1 Yr. Growth % | 2.1 | 16.36 | -1.76 | 3.96 | -3.28 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.14 | 12.33 | 2.84 | 8.94 | -6.49 | |||||
Common Equity, 1 Yr. Growth % | 11.59 | 10.6 | 3.05 | 7.66 | -5.39 | |||||
Cash From Operations, 1 Yr. Growth % | -100.77 | 1.05T | -828.05 | -22.43 | 42.97 | |||||
Capital Expenditures, 1 Yr. Growth % | -2.86 | 9.6 | 32.54 | 7.01 | -41.55 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 129.58 | 31.22 | -190.77 | -57.34 | 198.64 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 150.55 | 30.77 | -211.64 | -49.44 | 153.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 45.45 | 18.75 | 0 | 5.26 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.89 | 10.1 | 22.41 | 7.21 | 0.05 | |||||
Gross Profit, 2 Yr. CAGR % | 11 | 16.51 | 9.5 | 7.23 | 10.68 | |||||
EBITDA, 2 Yr. CAGR % | 9.96 | 33.24 | -3.92 | 2.15 | 26.16 | |||||
EBITA, 2 Yr. CAGR % | 7.05 | 45.53 | -8.97 | 0.02 | 34.05 | |||||
EBIT, 2 Yr. CAGR % | 7.01 | 45.67 | -9.16 | -0.32 | 34.02 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -0.25 | 18.09 | -7.82 | -7.4 | 16.86 | |||||
Net Income, 2 Yr. CAGR % | -2.35 | 14.67 | -1.9 | -5.48 | 19.3 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.12 | 47.13 | -10.36 | -2.09 | 38.85 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.96 | 14.64 | -1.92 | -5.5 | 19.25 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.8 | 5.6 | -16.46 | -26.15 | -0.17 | |||||
Inventory, 2 Yr. CAGR % | 4.63 | 26.32 | 17.64 | -1.7 | -4.19 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.36 | 4.01 | 6.87 | 9.75 | 3.12 | |||||
Total Assets, 2 Yr. CAGR % | 6.46 | 9 | 6.92 | 1.06 | 0.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14.21 | 13.23 | 7.48 | 5.85 | 0.93 | |||||
Common Equity, 2 Yr. CAGR % | 11.53 | 11.09 | 6.75 | 5.33 | 0.92 | |||||
Cash From Operations, 2 Yr. CAGR % | -93.59 | -29.24 | 815.86 | 137.65 | 5.31 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.69 | 1.44 | 20.53 | 19.09 | -20.91 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 251.82 | 75.22 | 9.26 | -37.77 | 11.78 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 161.57 | 82.87 | 20.97 | -24.87 | 12.33 | |||||
Dividend Per Share, 2 Yr. CAGR % | 33.33 | 31.43 | 8.97 | 2.6 | 7.61 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.55 | 11.95 | 10.98 | 15.16 | 4.13 | |||||
Gross Profit, 3 Yr. CAGR % | 11.16 | 14.02 | 10.26 | 11.76 | 6.55 | |||||
EBITDA, 3 Yr. CAGR % | 8.07 | 12.34 | 10.8 | 7.89 | 6.88 | |||||
EBITA, 3 Yr. CAGR % | 5.29 | 10.8 | 12.56 | 7.12 | 6.61 | |||||
EBIT, 3 Yr. CAGR % | 5.28 | 10.78 | 12.45 | 6.9 | 6.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.46 | 6.26 | -0.58 | 1.13 | -1.27 | |||||
Net Income, 3 Yr. CAGR % | 11.03 | 6.96 | -0.47 | 4.66 | 2.2 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.86 | 15.04 | 10.8 | 7.02 | 6.61 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.75 | 7.23 | -0.48 | 4.64 | 2.16 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.86 | 8.99 | -12.37 | -14.24 | -15.59 | |||||
Inventory, 3 Yr. CAGR % | 10.95 | 16.55 | 15.16 | 11.8 | -4.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 13.31 | 5.67 | 6.48 | 7.23 | 5.87 | |||||
Total Assets, 3 Yr. CAGR % | 10.66 | 9.66 | 5.29 | 5.92 | -0.41 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.82 | 13.58 | 9.66 | 7.97 | 1.57 | |||||
Common Equity, 3 Yr. CAGR % | 13.27 | 11.22 | 8.34 | 7.06 | 1.63 | |||||
Cash From Operations, 3 Yr. CAGR % | -82.68 | -35.52 | 53.9 | 302.21 | 100.62 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.3 | -0.59 | 10.9 | 15.84 | -6.06 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 86.72 | 154.86 | 40.83 | -20.15 | 4.29 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 59.74 | 109.03 | 55.26 | -9.56 | 12.1 | |||||
Dividend Per Share, 3 Yr. CAGR % | 21.14 | 28.28 | 19.98 | 7.72 | 5.01 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.8 | 11.07 | 12.58 | 10.03 | 6.48 | |||||
Gross Profit, 5 Yr. CAGR % | 15.47 | 12.18 | 10.29 | 11.25 | 10.43 | |||||
EBITDA, 5 Yr. CAGR % | 13.34 | 8.41 | 2.55 | 8.12 | 16.71 | |||||
EBITA, 5 Yr. CAGR % | 10.98 | 6.43 | -1.38 | 6.32 | 20.71 | |||||
EBIT, 5 Yr. CAGR % | 11.03 | 6.43 | -1.47 | 6.17 | 20.63 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.89 | 8.96 | 3.31 | 0.57 | 6.06 | |||||
Net Income, 5 Yr. CAGR % | 3.51 | 10.1 | 5.66 | 1.8 | 7.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.04 | 11.32 | -0.95 | 7.86 | 21.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.91 | 11.77 | 5.5 | 1.95 | 6.98 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.57 | 12.73 | -1.54 | -6.72 | -7.68 | |||||
Inventory, 5 Yr. CAGR % | 9.35 | 15.34 | 13.58 | 8.87 | 6.99 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.49 | 10.97 | 10.69 | 7.28 | 5.12 | |||||
Total Assets, 5 Yr. CAGR % | 8.97 | 11.68 | 9.15 | 6.14 | 3.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | 26.66 | 20.58 | 11.24 | 10.42 | 6.08 | |||||
Common Equity, 5 Yr. CAGR % | 21.23 | 17.59 | 10.62 | 8.82 | 5.31 | |||||
Cash From Operations, 5 Yr. CAGR % | -59.47 | -33.12 | 19.83 | 8.65 | 32.23 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.95 | 5.75 | 7.85 | 6.86 | -3.13 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.26 | -6.3 | 51.27 | 45.06 | 28.4 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.87 | -9.13 | 43.51 | 38.88 | 36.41 | |||||
Dividend Per Share, 5 Yr. CAGR % | 29.28 | 16.12 | 16.12 | 17.32 | 14.87 |
- Stock Market
- Equities
- GODREJAGRO Stock
- Financials Godrej Agrovet Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















